Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Ameos HY results show competitive growth

German PE-backed psychiatry specialist Ameos has made a number of small acquisitions this year which have contributed to competitive growth rates for the company. Ameos has the largest focus on psychiatry and mental health among German hospital groups, with revenues in the sector at €426m in 2018, over half of total turnover. 

Orpea enters the UK with acquisition in psychiatry

Pan-European nursing home and psychiatric giant Orpea has entered the UK market for the first time. The group has bought a French psychiatric specialist which owns a premium facility in London. HBI speaks to Orpea and a market adviser about strategy, multiples, and whether this opens the door to further activity in the UK.

France’s third largest lab group ‘for sale’

One of France's largest lab groups, Inovie, has appointed France-based international bank BNP Paribas to explore potential financing - but its complex shareholder structure and president's public objection to external investment leaves open questions about how any sale could work.

Penta courts investors

HBI can exclusively reveal that multi-national CEE hospital chain Penta has started meeting with investors with a view to selling at least a minority stake, months after it denied the company was for sale. It tells HBI that it wants a partner who can support international expansion plans.

Spire divests oncology centres to GenesisCare

Quoted UK hospital group Spire has sold its two oncology centres to specialist provider GenesisCare, while together they have entered into a JV to deliver oncology services at one of Spire's hospitals. Its CEO suggests a further divestment could be on the cards.

Althea and Medipass may sell as TPM equipment sector hots up

Althea, by far the largest player in the third party managed equipment market in EMEA has been put up for sale by Permira, as first reported here in 2018. Meanwhile, we hear listed Italian player KOS is pondering the sale of Medipass.

MedLife makes first foray onto oncology market

Listed Romanian healthcare group MedLife has entered the oncology market for the first time, acquiring a majority stake in a Bucharest provider. We speak to a market expert about the move.

IHH buys hospital from major shareholder

Pan-Asian hospital group IHH Healthcare Berhad is further consolidating its strong position in Malaysia with the acquisition of a substantial private medical centre in its capital, Kuala Lumpur.

Find Us